Close
  Indian J Med Microbiol
 

Figure 3: Changes in inflammatory lesion count in Groups A (nadifloxacin and benzoyl peroxide) and B (adapalene and benzoyl peroxide). Inflammatory lesion count (mean ± standard deviation) in Group A are 4.64 ± 0.4, 2.64 ± 0.3, 1.47 ± 0.2, 0.59 ± 0.1 at weeks 0, 4, 8, 12 respectively; in Group B are 5.44 ± 0.6, 1.94 ± 0.3, 0.64 ± 0.2, 0.22 ± 0.1 at weeks 0, 4, 8, 12 respectively. *P< 0.05 and **P< 0.05-weeks 4, 8,12 versus week 0 in Groups A and B respectively. Intergroup comparison of noninflammatory lesion count levels at weeks 4, 8, and 12: ##P< 0.05 - Group A versus B at week 8. #P< 0.05 - Group A versus B at week 12

Figure 3: Changes in inflammatory lesion count in Groups A (nadifloxacin and benzoyl peroxide) and B (adapalene and benzoyl peroxide). Inflammatory lesion count (mean ± standard deviation) in Group A are 4.64 ± 0.4, 2.64 ± 0.3, 1.47 ± 0.2, 0.59 ± 0.1 at weeks 0, 4, 8, 12 respectively; in Group B are 5.44 ± 0.6, 1.94 ± 0.3, 0.64 ± 0.2, 0.22 ± 0.1 at weeks 0, 4, 8, 12 respectively. *<i>P</i>< 0.05 and **<i>P</i>< 0.05-weeks 4, 8,12 versus week 0 in Groups A and B respectively. Intergroup comparison of noninflammatory lesion count levels at weeks 4, 8, and 12: <sup>##</sup><i>P</i>< 0.05 - Group A versus B at week 8. <sup>#</sup><i>P</i>< 0.05 - Group A versus B at week 12